DOP48 Amiselimod, a selective S1P receptor modulator in...

DOP48 Amiselimod, a selective S1P receptor modulator in Crohn’s disease patients: a proof-of-concept study

D’Haens, G, Danese, S, Davies, M, Watanabe, M, Hibi, T
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.082
Date:
January, 2019
File:
PDF, 429 KB
2019
Conversion to is in progress
Conversion to is failed